Chinook Therapeutics to Present at Upcoming Investor Conferences
VANCOUVER, British Columbia and SEATTLE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused...
Day: January 4, 2021
Celldex Appoints Freddy A. Jimenez, Esq. as Senior Vice President and General Counsel
HAMPTON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced the promotion of Freddy A. Jimenez,...
RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro...
Selecta Biosciences to Participate in the H.C. Wainwright BioConnect 2021 Conference
WATERTOWN, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
89bio to Participate in the H.C. Wainwright BioConnect 2021 Conference
SAN FRANCISCO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January
NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing...
Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells
-Phase 1a trial achieved primary objective of safety and tolerability-PT101 induced potent and selective expansion of regulatory T cells exceeding...
F-star Therapeutics Announces First Patient Dosed in FS222 Phase 1 Clinical Trial
FS222 is a potentially best-in-class bispecific antibody targeting CD137 (4-1BB) and PD-L1, and is the Company’s third bispecific to enter...
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference
WARMINSTER, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF
Gregory P. Cosgrove, M.D., FCCP, Pliant Vice President of Clinical Development (IPF) Dr. Cosgrove will focus on the strategic execution...
Cabaletta Bio to Participate in Upcoming January Investor Conferences
PHILADELPHIA, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
Ayala Pharmaceuticals to Accelerate Development of AL102 for the Treatment of Desmoid Tumors in Pivotal Phase 2/3 Study
- FDA Agreement from End-of-Phase 1 Meeting to Advance to Potential Registrational Study - - Pivotal Trial Expected to Initiate...
Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma’s Acquisition of Arvelle Therapeutics
Company to receive up to $20 million in upfront and milestone payments from non-dilutive transactionTransaction extends cash runway into 2022NEW...
ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™
RAMSEY, N.J. and BOCA RATON, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial...
Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
Eledon to commence trading on the Nasdaq exchange under the ticker “ELDN” effective tomorrow, January 5, 2021 Eledon is well...
MiMedx to Participate at the H.C. Wainwright BioConnect 2021 Conference
MARIETTA, Ga., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
ORYZON to Present a Corporate Update and to Hold Multiple Virtual Corporate Activities in January 2021
To present recent progress of clinical pipeline at the H.C. Wainwright Bioconnect ConferenceWill participate in LifeSci Advisors’ 10th Annual LifeSci...
Better Choice Appoints Consumer Packaged Goods Industry Veteran, Scott Lerner, as New CEO
With over 20 years of experience in the consumer packaged goods industry, Mr. Lerner has previously held positions at PepsiCo,...
Inovalon Announces Charitable Initiatives for 2020
Inovalon Continues Longstanding Support of Local and National Organizations through Social Responsibility Program BOWIE, Md., Jan. 04, 2021 (GLOBE NEWSWIRE)...